Agnantis NJ - Search Results

1

The lipophilic extract of Hypericum perforatum exerts significant cytotoxic activity against T24 and NBT-II urinary bladder tumor cells.

Skalkos D, Stavropoulos NE, Tsimaris I, Gioti E, Stalikas CD, Nseyo UO, Ioachim E, Agnantis NJ. Skalkos D, et al. Among authors: agnantis nj. Planta Med. 2005 Nov;71(11):1030-5. doi: 10.1055/s-2005-873127. Planta Med. 2005. PMID: 16320204

2

Lymphocyte subsets in superficial bladder cancer: correlation with biological activity of the tumours.

Stavropoulos NE, Ioachim E, Hastazeris K, Goussia A, Agnantis NJ. Stavropoulos NE, et al. Among authors: agnantis nj. Anticancer Res. 1998 May-Jun;18(3B):2037-40. Anticancer Res. 1998. PMID: 9677463

3

Antiproliferative activity of interferon gamma in superficial bladder cancer.

Stavropoulos NE, Ioachim E, Pappa L, Hastazeris K, Agnantis NJ. Stavropoulos NE, et al. Among authors: agnantis nj. Anticancer Res. 1999 Sep-Oct;19(5C):4529-33. Anticancer Res. 1999. PMID: 10650805

4

Immunohistochemical expression of retinoblastoma gene product (Rb), p53 protein, MDM2, c-erbB-2, HLA-DR and proliferation indices in human urinary bladder carcinoma.

Ioachim E, Charchanti A, Stavropoulos NE, Skopelitou A, Athanassiou ED, Agnantis NJ. Ioachim E, et al. Among authors: agnantis nj. Histol Histopathol. 2000 Jul;15(3):721-7. doi: 10.14670/HH-15.721. Histol Histopathol. 2000. PMID: 10963116

5

Localization of metallothionein in urothelial carcinoma of the human urinary bladder: an immunohistochemical study including correlation with HLA-DR antigen, p53, and proliferation indices.

Ioachim EE, Charchanti AV, Stavropoulos NE, Athanassiou ED, Michael MC, Agnantis NJ. Ioachim EE, et al. Among authors: agnantis nj. Anticancer Res. 2001 May-Jun;21(3B):1757-61. Anticancer Res. 2001. PMID: 11497256

6

Immunohistochemical prognostic markers in bladder cancer.

Ioachim E, Stavropoulos NE, Charalabopoulos K, Agnantis NJ. Ioachim E, et al. Among authors: agnantis nj. J BUON. 2002 Jul-Sep;7(3):207-16. J BUON. 2002. PMID: 17918790

7

Tumor markers in stage P1 bladder cancer.

Stavropoulos NE, Ioachim E, Charchanti A, Michael MC, Kitsiou E, Mihailidis I, Hastazeris K, Agnantis NJ. Stavropoulos NE, et al. Among authors: agnantis nj. Anticancer Res. 2001 Mar-Apr;21(2B):1495-8. Anticancer Res. 2001. PMID: 11396238

8

Expression of cathepsin D in urothelial carcinoma of the urinary bladder: an immunohistochemical study including correlations with extracellular matrix components, CD44, p53, Rb, c-erbB-2 and the proliferation indices.

Ioachim E, Charchanti A, Stavropoulos N, Athanassiou E, Bafa M, Agnantis NJ. Ioachim E, et al. Among authors: agnantis nj. Anticancer Res. 2002 Nov-Dec;22(6A):3383-8. Anticancer Res. 2002. PMID: 12530091

9

Local immune response after intravesical interferon gamma in superficial bladder cancer.

Stavropoulos NE, Ioachim E, Pavlidis N, Pappa L, Kalomiris P, Agnantis NJ. Stavropoulos NE, et al. Among authors: agnantis nj. Br J Urol. 1998 Jun;81(6):875-9. doi: 10.1046/j.1464-410x.1998.00646.x. Br J Urol. 1998. PMID: 9666774

10

Prostate cancer epidemiology in a rural area of North Western Greece.

Grivas N, Hastazeris K, Kafarakis V, Tsimaris I, Xousianitis Z, Makatsori A, Raptis P, Aspiotis S, Ioachim E, Ntemou A, Kitsiou E, Malamou-Mitsi V, Sofikitis N, Kordela V, Papandreou C, Agnantis NJ, Stavropoulos NE. Grivas N, et al. Among authors: agnantis nj. Asian Pac J Cancer Prev. 2012;13(3):999-1002. doi: 10.7314/apjcp.2012.13.3.999. Asian Pac J Cancer Prev. 2012. PMID: 22631687 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

238 results

Search Page